|
|
|
|
|
|
|
|
|
|
Previous: BIOTRANSPLANT INC, 10-Q, EX-10.1, 2000-11-13 |
Next: BIOTRANSPLANT INC, 10-Q, EX-99.1, 2000-11-13 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED BALANCE SHEET OF SEPTEMBER 30, 2000 AND THE CONDENSED CONSOLIDATED
STATEMENT OF OPERATIONS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 14,517,476
<SECURITIES> 4,863,052
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 19,892,821
<PP&E> 5,441,290
<DEPRECIATION> 4,125,129
<TOTAL-ASSETS> 21,208,982
<CURRENT-LIABILITIES> 2,893,679
<BONDS> 0
0
0
<COMMON> 117,058
<OTHER-SE> 17,892,942
<TOTAL-LIABILITY-AND-EQUITY> 21,208,982
<SALES> 0
<TOTAL-REVENUES> 5,502,238
<CGS> 0
<TOTAL-COSTS> 12,909,885
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 46,653
<INCOME-PRETAX> (7,407,647)
<INCOME-TAX> 0
<INCOME-CONTINUING> (7,407,647)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (7,407,647)
<EPS-BASIC> (0.65)
<EPS-DILUTED> (0.65)
</TABLE>
|
|